13.Feb.202413.Feb.202422.Nov.202312.Jun.202326.May.202312.May.202326.Apr.202320.Oct.202212.Oct.202205.Oct.202223.Jun.2022東京証券取引所グロース市場への上場に関するお知らせ
20.May.2022東京証券取引所グロース市場への上場承認に関するお知らせ
13.Oct.202120.Sep.202119.Sep.202126.Aug.202125.May.2021World’s first discovery of the molecular mechanisms of violet light for myopia: Violet light suppresses myopia progression via the non-visual photoreceptor, OPN5.
21.May.2021Major milestone in exploratory clinical trial for a medical device: Confirmation of the suppressive effect of violet light on myopia progression
01.Feb.2021Case Report of Axial Length Shortening in a High Myopic Child After Wearing Violet Light-Transmitting Eyeglasses
23.Dec.2020A major step in the development of a medical device for the suppression of myopia progression Safety was confirmed in the exploratory clinical trial
07.Dec.2020研究員募集のお知らせ
